178 related articles for article (PubMed ID: 30310812)
1. Corrigendum: Hyaluronan, Cancer-Associated Fibroblasts and the Tumor Microenvironment in Malignant Progression.
McCarthy JB; El-Ashry D; Turley EA
Front Cell Dev Biol; 2018; 6():112. PubMed ID: 30310812
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronan, Cancer-Associated Fibroblasts and the Tumor Microenvironment in Malignant Progression.
McCarthy JB; El-Ashry D; Turley EA
Front Cell Dev Biol; 2018; 6():48. PubMed ID: 29868579
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum: MicroRNA-138-5p Suppresses Non-small Cell Lung Cancer Cells by Targeting PD-L1/PD-1 to Regulate Tumor Microenvironment.
Song N; Li P; Song P; Li Y; Zhou S; Su Q; Li X; Yu Y; Li P; Feng M; Zhang M; Lin W
Front Cell Dev Biol; 2020; 8():746. PubMed ID: 32974332
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum: Chronic Stress: Impacts on Tumor Microenvironment and Implications for Anti-Cancer Treatments.
Tian W; Liu Y; Cao C; Zeng Y; Pan Y; Liu X; Peng Y; Wu F
Front Cell Dev Biol; 2022; 10():865043. PubMed ID: 35317388
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronan, Inflammation, and Breast Cancer Progression.
Schwertfeger KL; Cowman MK; Telmer PG; Turley EA; McCarthy JB
Front Immunol; 2015; 6():236. PubMed ID: 26106384
[TBL] [Abstract][Full Text] [Related]
6. Corrigendum: Lipid metabolism and tumor immunotherapy.
Wang Y; Guo Z; Isah AD; Chen S; Ren Y; Cai H
Front Cell Dev Biol; 2024; 12():1349379. PubMed ID: 38344750
[TBL] [Abstract][Full Text] [Related]
7. Corrigendum: MicroRNA-16-1-3p Represses Breast Tumor Growth and Metastasis by Inhibiting PGK1-Mediated Warburg Effect.
Ye T; Liang Y; Zhang D; Zhang X
Front Cell Dev Biol; 2021; 9():649787. PubMed ID: 33553193
[TBL] [Abstract][Full Text] [Related]
8. Corrigendum: TKI-Resistant Renal Cancer Secretes Low-Level Exosomal miR-549a to Induce Vascular Permeability and Angiogenesis to Promote Tumor Metastasis.
Xuan Z; Chen C; Tang W; Ye S; Zheng J; Zhao Y; Shi Z; Zhang L; Sun H; Shao C
Front Cell Dev Biol; 2021; 9():726535. PubMed ID: 34350190
[TBL] [Abstract][Full Text] [Related]
9. Corrigendum: Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis.
Wang G; Dai Y; Li K; Cheng M; Xiong G; Wang X; Chen S; Chen Z; Chen J; Xu X; Ling RS; Peng L; Chen D
Front Cell Dev Biol; 2021; 9():675417. PubMed ID: 33842490
[TBL] [Abstract][Full Text] [Related]
10. Corrigendum: PET/Ct Imaging of Activated Cancer-Associated Fibroblasts Predict Response to PD-1 Blockade in Gastric Cancer Patients.
Rong X; Lv J; Liu Y; Wang Z; Zeng D; Li Y; Li S; Wu J; Shen Z; Shi M; Liao W; Wu Z; Wang C
Front Oncol; 2022; 12():895938. PubMed ID: 35463347
[TBL] [Abstract][Full Text] [Related]
11. p38MAPK builds a hyaluronan cancer niche to drive lung tumorigenesis.
Brichkina A; Bertero T; Loh HM; Nguyen NT; Emelyanov A; Rigade S; Ilie M; Hofman P; Gaggioli C; Bulavin DV
Genes Dev; 2016 Dec; 30(23):2623-2636. PubMed ID: 28007785
[TBL] [Abstract][Full Text] [Related]
12. Breast Cancer-Associated Fibroblasts: Where We Are and Where We Need to Go.
Buchsbaum RJ; Oh SY
Cancers (Basel); 2016 Jan; 8(2):. PubMed ID: 26828520
[TBL] [Abstract][Full Text] [Related]
13. Dissecting the Dual Nature of Hyaluronan in the Tumor Microenvironment.
Liu M; Tolg C; Turley E
Front Immunol; 2019; 10():947. PubMed ID: 31134064
[TBL] [Abstract][Full Text] [Related]
14. The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis.
Xu K; Tian X; Oh SY; Movassaghi M; Naber SP; Kuperwasser C; Buchsbaum RJ
Breast Cancer Res; 2016 Jan; 18(1):14. PubMed ID: 26821678
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronan: A modulator of the tumor microenvironment.
Chanmee T; Ontong P; Itano N
Cancer Lett; 2016 May; 375(1):20-30. PubMed ID: 26921785
[TBL] [Abstract][Full Text] [Related]
16. DT-13 inhibits cancer cell migration by regulating NMIIA indirectly in the tumor microenvironment.
Du H; Huang Y; Hou X; Yu X; Lin S; Wei X; Li R; Khan GJ; Yuan S; Sun L
Oncol Rep; 2016 Aug; 36(2):721-8. PubMed ID: 27350172
[TBL] [Abstract][Full Text] [Related]
17. Corrigendum: An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness.
Quan MY; Guo Q; Liu J; Yang R; Bai J; Wang W; Cai Y; Han R; Lv YQ; Ding L; Billadeau DD; Lou Z; Bellusci S; Li X; Zhang JS
Front Cell Dev Biol; 2020; 8():594589. PubMed ID: 33117821
[TBL] [Abstract][Full Text] [Related]
18. Altered hyaluronan biosynthesis in cancer progression.
Itano N; Kimata K
Semin Cancer Biol; 2008 Aug; 18(4):268-74. PubMed ID: 18450474
[TBL] [Abstract][Full Text] [Related]
19. Corrigendum: The m
Lin CX; Chen ZJ; Peng QL; Xiang KR; Xiao DQ; Chen RX; Cui T; Huang YS; Liu HW
Front Cell Dev Biol; 2023; 11():1144733. PubMed ID: 36798096
[TBL] [Abstract][Full Text] [Related]
20. Corrigendum: Personalized Medicine Approaches in Prostate Cancer Employing Patient Derived 3D Organoids and Humanized Mice.
Bartucci M; Ferrari AC; Kim IY; Ploss A; Yarmush M; Sabaawy HE
Front Cell Dev Biol; 2016; 4():74. PubMed ID: 27583246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
